Literature DB >> 31874800

Detection and characterization of mosaicism in autosomal dominant polycystic kidney disease.

Katharina Hopp1, Emilie Cornec-Le Gall2, Sarah R Senum3, Iris B A W Te Paske3, Sonam Raj3, Sravanthi Lavu3, Saurabh Baheti4, Marie E Edwards3, Charles D Madsen3, Christina M Heyer3, Albert C M Ong5, Kyongtae T Bae6, Richard Fatica7, Theodore I Steinman8, Arlene B Chapman9, Berenice Gitomer10, Ronald D Perrone11, Frederic F Rahbari-Oskoui12, Vicente E Torres3, Peter C Harris13.   

Abstract

Autosomal dominant polycystic kidney disease (ADPKD) is an inherited, progressive nephropathy accounting for 4-10% of end stage renal disease worldwide. PKD1 and PKD2 are the most common disease loci, but even accounting for other genetic causes, about 7% of families remain unresolved. Typically, these unsolved cases have relatively mild kidney disease and often have a negative family history. Mosaicism, due to de novo mutation in the early embryo, has rarely been identified by conventional genetic analysis of ADPKD families. Here we screened for mosaicism by employing two next generation sequencing screens, specific analysis of PKD1 and PKD2 employing long-range polymerase chain reaction, or targeted capture of cystogenes. We characterized mosaicism in 20 ADPKD families; the pathogenic variant was transmitted to the next generation in five families and sporadic in 15. The mosaic pathogenic variant was newly discovered by next generation sequencing in 13 families, and these methods precisely quantified the level of mosaicism in all. All of the mosaic cases had PKD1 mutations, 14 were deletions or insertions, and 16 occurred in females. Analysis of kidney size and function showed the mosaic cases had milder disease than a control PKD1 population, but only a few had clearly asymmetric disease. Thus, in a typical ADPKD population, readily detectable mosaicism by next generation sequencing accounts for about 1% of cases, and about 10% of genetically unresolved cases with an uncertain family history. Hence, identification of mosaicism is important to fully characterize ADPKD populations and provides informed prognostic information.
Copyright © 2019 International Society of Nephrology. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ADPKD; PKD1; diagnostics; genotype/phenotype correlations; mosaicism; mutations; prognostics

Mesh:

Substances:

Year:  2019        PMID: 31874800      PMCID: PMC7218796          DOI: 10.1016/j.kint.2019.08.038

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  34 in total

1.  Angiotensin blockade in late autosomal dominant polycystic kidney disease.

Authors:  Vicente E Torres; Kaleab Z Abebe; Arlene B Chapman; Robert W Schrier; William E Braun; Theodore I Steinman; Franz T Winklhofer; Godela Brosnahan; Peter G Czarnecki; Marie C Hogan; Dana C Miskulin; Frederic F Rahbari-Oskoui; Jared J Grantham; Peter C Harris; Michael F Flessner; Charity G Moore; Ronald D Perrone
Journal:  N Engl J Med       Date:  2014-11-15       Impact factor: 91.245

2.  Blood pressure in early autosomal dominant polycystic kidney disease.

Authors:  Robert W Schrier; Kaleab Z Abebe; Ronald D Perrone; Vicente E Torres; William E Braun; Theodore I Steinman; Franz T Winklhofer; Godela Brosnahan; Peter G Czarnecki; Marie C Hogan; Dana C Miskulin; Frederic F Rahbari-Oskoui; Jared J Grantham; Peter C Harris; Michael F Flessner; Kyongtae T Bae; Charity G Moore; Arlene B Chapman
Journal:  N Engl J Med       Date:  2014-11-15       Impact factor: 91.245

Review 3.  Autosomal dominant polycystic kidney disease.

Authors:  Vicente E Torres; Peter C Harris; Yves Pirson
Journal:  Lancet       Date:  2007-04-14       Impact factor: 79.321

4.  Monoallelic Mutations to DNAJB11 Cause Atypical Autosomal-Dominant Polycystic Kidney Disease.

Authors:  Emilie Cornec-Le Gall; Rory J Olson; Whitney Besse; Christina M Heyer; Vladimir G Gainullin; Jessica M Smith; Marie-Pierre Audrézet; Katharina Hopp; Binu Porath; Beili Shi; Saurabh Baheti; Sarah R Senum; Jennifer Arroyo; Charles D Madsen; Claude Férec; Dominique Joly; François Jouret; Oussamah Fikri-Benbrahim; Christophe Charasse; Jean-Marie Coulibaly; Alan S Yu; Korosh Khalili; York Pei; Stefan Somlo; Yannick Le Meur; Vicente E Torres; Peter C Harris
Journal:  Am J Hum Genet       Date:  2018-04-26       Impact factor: 11.025

5.  Polycystic Kidney Disease without an Apparent Family History.

Authors:  Ioan-Andrei Iliuta; Vinusha Kalatharan; Kairong Wang; Emilie Cornec-Le Gall; John Conklin; Marina Pourafkari; Ryan Ting; Chen Chen; Alessia C Borgo; Ning He; Xuewen Song; Christina M Heyer; Sarah R Senum; Young-Hwan Hwang; Andrew D Paterson; Peter C Harris; Korosh Khalili; York Pei
Journal:  J Am Soc Nephrol       Date:  2017-05-18       Impact factor: 10.121

6.  Factors affecting the progression of renal disease in autosomal-dominant polycystic kidney disease.

Authors:  P A Gabow; A M Johnson; W D Kaehny; W J Kimberling; D C Lezotte; I T Duley; R H Jones
Journal:  Kidney Int       Date:  1992-05       Impact factor: 10.612

7.  Characterization of large rearrangements in autosomal dominant polycystic kidney disease and the PKD1/TSC2 contiguous gene syndrome.

Authors:  Mark B Consugar; Wai C Wong; Patrick A Lundquist; Sandro Rossetti; Vickie J Kubly; Denise L Walker; Laureano J Rangel; Richard Aspinwall; W Patrick Niaudet; Seza Ozen; Albert David; Milen Velinov; Eric J Bergstralh; Kyongtae T Bae; Arlene B Chapman; Lisa M Guay-Woodford; Jared J Grantham; Vicente E Torres; Julian R Sampson; Brian D Dawson; Peter C Harris
Journal:  Kidney Int       Date:  2008-09-24       Impact factor: 10.612

8.  Comprehensive molecular diagnostics in autosomal dominant polycystic kidney disease.

Authors:  Sandro Rossetti; Mark B Consugar; Arlene B Chapman; Vicente E Torres; Lisa M Guay-Woodford; Jared J Grantham; William M Bennett; Catherine M Meyers; Denise L Walker; Kyongtae Bae; Qin Jean Zhang; Paul A Thompson; J Philip Miller; Peter C Harris
Journal:  J Am Soc Nephrol       Date:  2007-06-20       Impact factor: 10.121

9.  Somatic Mutations in Renal Cyst Epithelium in Autosomal Dominant Polycystic Kidney Disease.

Authors:  Adrian Y Tan; Tuo Zhang; Alber Michaeel; Jon Blumenfeld; Genyan Liu; Wanying Zhang; Zhengmao Zhang; Yi Zhu; Lior Rennert; Che Martin; Jenny Xiang; Steven P Salvatore; Brian D Robinson; Sandip Kapur; Stephanie Donahue; Warren O Bobb; Hanna Rennert
Journal:  J Am Soc Nephrol       Date:  2018-07-24       Impact factor: 10.121

10.  Diagnosis of autosomal dominant polycystic kidney disease using efficient PKD1 and PKD2 targeted next-generation sequencing.

Authors:  Daniel Trujillano; Gemma Bullich; Stephan Ossowski; José Ballarín; Roser Torra; Xavier Estivill; Elisabet Ars
Journal:  Mol Genet Genomic Med       Date:  2014-05-23       Impact factor: 2.183

View more
  15 in total

1.  The value of genotypic and imaging information to predict functional and structural outcomes in ADPKD.

Authors:  Sravanthi Lavu; Lisa E Vaughan; Sarah R Senum; Timothy L Kline; Arlene B Chapman; Ronald D Perrone; Michal Mrug; William E Braun; Theodore I Steinman; Frederic F Rahbari-Oskoui; Godela M Brosnahan; Kyongtae T Bae; Douglas Landsittel; Fouad T Chebib; Alan Sl Yu; Vicente E Torres; Peter C Harris
Journal:  JCI Insight       Date:  2020-08-06

2.  Asymptomatic Pyuria as a Prognostic Biomarker in Autosomal Dominant Polycystic Kidney Disease.

Authors:  Brian E Jones; Yaman G Mkhaimer; Laureano J Rangel; Maroun Chedid; Phillip J Schulte; Alaa K Mohamed; Reem M Neal; Dalia Zubidat; Amarjyot K Randhawa; Christian Hanna; Adriana V Gregory; Timothy L Kline; Ziad M Zoghby; Sarah R Senum; Peter C Harris; Vicente E Torres; Fouad T Chebib
Journal:  Kidney360       Date:  2021-12-07

3.  Novel somatic PBX1 mosaicism likely masking syndromic CAKUT in an adult with bilateral kidney hypoplasia.

Authors:  Friederike Petzold; Wenjun Jin; Elena Hantmann; Katharina Korbach; Ria Schönauer; Jan Halbritter
Journal:  Clin Kidney J       Date:  2022-04-06

4.  Monoallelic IFT140 pathogenic variants are an important cause of the autosomal dominant polycystic kidney-spectrum phenotype.

Authors:  Sarah R Senum; Ying Sabrina M Li; Katherine A Benson; Giancarlo Joli; Eric Olinger; Sravanthi Lavu; Charles D Madsen; Adriana V Gregory; Ruxandra Neatu; Timothy L Kline; Marie-Pierre Audrézet; Patricia Outeda; Cherie B Nau; Esther Meijer; Hamad Ali; Theodore I Steinman; Michal Mrug; Paul J Phelan; Terry J Watnick; Dorien J M Peters; Albert C M Ong; Peter J Conlon; Ronald D Perrone; Emilie Cornec-Le Gall; Marie C Hogan; Vicente E Torres; John A Sayer; Peter C Harris
Journal:  Am J Hum Genet       Date:  2021-12-09       Impact factor: 11.043

5.  Use of the Urine-to-Plasma Urea Ratio to Predict ADPKD Progression.

Authors:  Judith E Heida; Ron T Gansevoort; A Lianne Messchendorp; Esther Meijer; Niek F Casteleijn; Wendy E Boertien; Debbie Zittema
Journal:  Clin J Am Soc Nephrol       Date:  2021-01-27       Impact factor: 8.237

6.  The genetic background significantly impacts the severity of kidney cystic disease in the Pkd1RC/RC mouse model of autosomal dominant polycystic kidney disease.

Authors:  Jennifer Arroyo; Diana Escobar-Zarate; Harrison H Wells; Megan M Constans; Ka Thao; Jessica M Smith; Cynthia J Sieben; Madeline R Martell; Timothy L Kline; Maria V Irazabal; Vicente E Torres; Katharina Hopp; Peter C Harris
Journal:  Kidney Int       Date:  2021-03-09       Impact factor: 18.998

7.  Characteristics of Patients with End-Stage Kidney Disease in ADPKD.

Authors:  Shehbaz S Shukoor; Lisa E Vaughan; Marie E Edwards; Sravanthi Lavu; Timothy L Kline; Sarah R Senum; Yaman Mkhaimer; Ghaith Zaatari; Maria V Irazabal; Reem Neal; Marie C Hogan; Ziad M Zoghby; Peter C Harris; Vicente E Torres; Fouad T Chebib
Journal:  Kidney Int Rep       Date:  2020-12-31

8.  Genomics Integration Into Nephrology Practice.

Authors:  Filippo Pinto E Vairo; Carri Prochnow; Jennifer L Kemppainen; Emily C Lisi; Joan M Steyermark; Teresa M Kruisselbrink; Pavel N Pichurin; Rhadika Dhamija; Megan M Hager; Sam Albadri; Lynn D Cornell; Konstantinos N Lazaridis; Eric W Klee; Sarah R Senum; Mireille El Ters; Hatem Amer; Linnea M Baudhuin; Ann M Moyer; Mira T Keddis; Ladan Zand; David J Sas; Stephen B Erickson; Fernando C Fervenza; John C Lieske; Peter C Harris; Marie C Hogan
Journal:  Kidney Med       Date:  2021-06-29

Review 9.  Insights into Autosomal Dominant Polycystic Kidney Disease from Genetic Studies.

Authors:  Matthew B Lanktree; Amirreza Haghighi; Ighli di Bari; Xuewen Song; York Pei
Journal:  Clin J Am Soc Nephrol       Date:  2020-07-20       Impact factor: 8.237

10.  Primary results of the randomized trial of metformin administration in polycystic kidney disease (TAME PKD).

Authors:  Ronald D Perrone; Kaleab Z Abebe; Terry J Watnick; Andrew D Althouse; Kenneth R Hallows; Christina M Lalama; Dana C Miskulin; Stephen L Seliger; Cheng Tao; Peter C Harris; Kyongtae Ty Bae
Journal:  Kidney Int       Date:  2021-06-27       Impact factor: 18.998

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.